Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Criteria

Inclusion criteria:

• Healty Japanese men willing to use a medically acceptable form of contraception.

Exclusion criteria:

• Any significant disease

• Positive urine drug screen

• Increased liver function tests

• Use of prescription drugs.